These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35091264)

  • 1. Large HDL particles negatively associate with leukocyte counts independent of cholesterol efflux capacity: A cross sectional study in the population-based LifeLines DEEP cohort.
    Groenen AG; Bazioti V; van Zeventer IA; Chen L; Groot HE; Balder JW; Zhernakova A; van der Harst P; Rimbert A; Kuivenhoven JA; Fu J; Westerterp M
    Atherosclerosis; 2022 Feb; 343():20-27. PubMed ID: 35091264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.
    Ahmed MO; Byrne RE; Pazderska A; Segurado R; Guo W; Gunness A; Frizelle I; Sherlock M; Ahmed KS; McGowan A; Moore K; Boran G; McGillicuddy FC; Gibney J
    Diabetologia; 2021 Mar; 64(3):656-667. PubMed ID: 33169205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoprotein cholesterol efflux capacity is not associated with atherosclerosis and prevalence of cardiovascular outcome: The CODAM study.
    Josefs T; Wouters K; Tietge UJF; Annema W; Dullaart RPF; Vaisar T; Arts ICW; van der Kallen CJH; Stehouwer CDA; Schalkwijk CG; Goldberg IJ; Fisher EA; van Greevenbroek MMJ
    J Clin Lipidol; 2020; 14(1):122-132.e4. PubMed ID: 31791716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of plasma lipids with white blood cell counts: Results from the Multi-Ethnic Study of Atherosclerosis.
    Lai YC; Woollard KJ; McClelland RL; Allison MA; Rye KA; Ong KL; Cochran BJ
    J Clin Lipidol; 2019; 13(5):812-820. PubMed ID: 31402296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study).
    Akinmolayemi O; Saldanha S; Joshi PH; Deodhar S; Ayers CR; Neeland IJ; Rohatgi A
    PLoS One; 2021; 16(9):e0257574. PubMed ID: 34547056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population.
    Ebtehaj S; Gruppen EG; Bakker SJL; Dullaart RPF; Tietge UJF
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1874-1883. PubMed ID: 31315436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of serum lipid and lipoprotein levels with total and differential leukocyte counts: Results of a cross-sectional and longitudinal analysis of the UK Biobank.
    Tucker B; Sawant S; McDonald H; Rye KA; Patel S; Ong KL; Cochran BJ
    Atherosclerosis; 2021 Feb; 319():1-9. PubMed ID: 33453490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-Scale Analysis of Determinants, Stability, and Heritability of High-Density Lipoprotein Cholesterol Efflux Capacity.
    Koekemoer AL; Codd V; Masca NGD; Nelson CP; Musameh MD; Kaess BM; Hengstenberg C; Rader DJ; Samani NJ
    Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1956-1962. PubMed ID: 28860221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoprotein functionality in cholesterol efflux in early childhood is related to the content ratio of triglyceride to cholesterol.
    Futatsugi A; Tozuka M; Horiuchi Y; Ohkawa R; Kosho T
    Sci Rep; 2024 Oct; 14(1):23323. PubMed ID: 39375444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
    van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
    Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between leukocyte counts and cardiovascular disease risk factors in apparently healthy Japanese men.
    Mochizuki K; Miyauchi R; Misaki Y; Kasezawa N; Tohyama K; Goda T
    J Nutr Sci Vitaminol (Tokyo); 2012; 58(3):181-6. PubMed ID: 22878388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and observational evidence: No independent role for cholesterol efflux over static high-density lipoprotein concentration measures in coronary heart disease risk assessment.
    Kuusisto S; Karjalainen MK; Tillin T; Kangas AJ; Holmes MV; Kähönen M; Lehtimäki T; Viikari J; Perola M; Chaturvedi N; Salomaa V; Raitakari OT; Järvelin MR; Kettunen J; Ala-Korpela M
    J Intern Med; 2022 Jul; 292(1):146-153. PubMed ID: 35289444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low High-Density Lipoprotein Cholesterol and High White Blood Cell Counts: A Mendelian Randomization Study.
    Harsløf M; Pedersen KM; Nordestgaard BG; Afzal S
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):976-987. PubMed ID: 33327746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased ABCA1 (ATP-Binding Cassette Transporter A1)-Specific Cholesterol Efflux Capacity in Schizophrenia.
    Luquain-Costaz C; Kockx M; Anastasius M; Chow V; Kontush A; Jessup W; Kritharides L
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2728-2737. PubMed ID: 32907370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study.
    Gourgari E; Playford MP; Campia U; Dey AK; Cogen F; Gubb-Weiser S; Mete M; Desale S; Sampson M; Taylor A; Rother KI; Remaley AT; Mehta NN
    Cardiovasc Diabetol; 2018 Dec; 17(1):158. PubMed ID: 30567548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause.
    El Khoudary SR; Hutchins PM; Matthews KA; Brooks MM; Orchard TJ; Ronsein GE; Heinecke JW
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3419-28. PubMed ID: 27399353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity CRP may be a marker of HDL dysfunction and remodeling in patients with acute coronary syndrome.
    Tang X; Mao L; Chen J; Zhang T; Weng S; Guo X; Kuang J; Yu B; Peng D
    Sci Rep; 2021 Jun; 11(1):11444. PubMed ID: 34075063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.
    van Capelleveen JC; Kastelein JJ; Zwinderman AH; van Deventer SJ; Collins HL; Adelman SJ; Round P; Ford J; Rader DJ; Hovingh GK
    J Clin Lipidol; 2016; 10(5):1137-1144.e3. PubMed ID: 27678430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.
    Roe A; Hillman J; Butts S; Smith M; Rader D; Playford M; Mehta NN; Dokras A
    J Clin Endocrinol Metab; 2014 May; 99(5):E841-7. PubMed ID: 24512495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.
    Asztalos BF; Hauser TH; Goldfine AB; Welty FK; Horvath KV; Schaefer EJ
    Atherosclerosis; 2022 Mar; 345():1-6. PubMed ID: 35183903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.